<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Netvouz - link info</title>
<link>http://netvouz.com/url/34f8797d62714812b1adf29e7873ef6c?feed=rss</link>
<description>Info about a link</description>
<item><title>Medarex and Northwest Biotherapeutics Announce Alliance To Develop New Cancer Therapies</title>
<link>http://www.medarex.com/cgi-local/item.pl/20010425-555473</link>
<description>Good site on Cancer research</description>
<category domain="http://netvouz.com/anisharocks22?category=3220206951471247746"></category>
<author>anisharocks22</author>
<pubDate>Fri, 30 Nov 2007 18:44:04 GMT</pubDate>
</item><item><title>Medarex and Northwest Biotherapeutics Announce Alliance To Develop New Cancer Therapies</title>
<link>http://www.medarex.com/cgi-local/item.pl/20010425-555473</link>
<description>Northwest Biotherapeutics, Inc. is a privately held company founded in 1996 to develop and commercialize products and services to improve care for cancer patients. In addition to developing fully human antibody-based cancer treatments with Medarex, NWBio</description>
<category domain="http://netvouz.com/abrahamcoleman7?category=2782613915410668423"></category>
<author>abrahamcoleman7</author>
<pubDate>Tue, 27 Nov 2007 01:34:24 GMT</pubDate>
</item><item><title>Medarex and Northwest Biotherapeutics Announce Alliance To Develop New Cancer Therapies</title>
<link>http://www.medarex.com/cgi-local/item.pl/20010425-555473</link>
<description>Northwest Biotherapeutics intends to initially contribute four of its existing cancer related targets, and over the next several years, NWBio will contribute four additional, yet to be determined, cancer targets to the alliance&#39;s fully human antibody-base</description>
<category domain="http://netvouz.com/lindaedwards?category=4225883575281521968"></category>
<author>lindaedwards</author>
<pubDate>Thu, 22 Nov 2007 03:22:38 GMT</pubDate>
</item></channel></rss>